Russell Portenoy

Summary

Affiliation: Beth Israel Medical Center
Country: USA

Publications

  1. ncbi request reprint Advances in cancer pain management
    Annette Vielhaber
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, First Avenue at 16th Street, New York, NY 10003, USA
    Hematol Oncol Clin North Am 16:527-41. 2002
  2. ncbi request reprint Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain
    Russell K Portenoy
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 10003, USA
    J Pain 7:583-91. 2006
  3. ncbi request reprint Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study
    Russell K Portenoy
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 10003, USA
    Clin J Pain 23:287-99. 2007
  4. ncbi request reprint Development and testing of a neuropathic pain screening questionnaire: ID Pain
    Russell Portenoy
    Beth Israel Medical Center, First Avenue at 16th Street, New York, NY 10003, USA
    Curr Med Res Opin 22:1555-65. 2006
  5. ncbi request reprint Appropriate use of opioids for persistent non-cancer pain
    Russell K Portenoy
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 10003, USA
    Lancet 364:739-40. 2004
  6. doi request reprint A multicenter, placebo-controlled, double-blind, multiple-crossover study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain
    Russell K Portenoy
    Beth Israel Medical Center, New York, NY 10003, USA
    Pain 151:617-24. 2010
  7. ncbi request reprint Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study
    Russell K Portenoy
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 0003, USA
    Curr Med Res Opin 23:223-33. 2007
  8. ncbi request reprint A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer
    Russell K Portenoy
    Beth Israel Medical Center, New York, NY 10003, USA
    Clin J Pain 22:805-11. 2006
  9. ncbi request reprint Opioid use and survival at the end of life: a survey of a hospice population
    Russell K Portenoy
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, New York 10003, USA
    J Pain Symptom Manage 32:532-40. 2006
  10. ncbi request reprint Safety and tolerability of high doses of intrathecal fentanyl for the treatment of chronic pain
    Sulane Do Ouro
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY, USA
    J Opioid Manag 2:365-8. 2006

Detail Information

Publications61

  1. ncbi request reprint Advances in cancer pain management
    Annette Vielhaber
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, First Avenue at 16th Street, New York, NY 10003, USA
    Hematol Oncol Clin North Am 16:527-41. 2002
    ..With a detailed assessment, clinicians should be able to choose among the large and diverse group of options available and implement an approach, or combination of approaches, that have a high probability of improving analgesic outcomes...
  2. ncbi request reprint Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain
    Russell K Portenoy
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 10003, USA
    J Pain 7:583-91. 2006
    ..Breakthrough pain is highly prevalent and varied in this population. Further studies are warranted to clarify whether the clinical impact and therapeutic challenges posed by this phenomenon are comparable to the cancer population...
  3. ncbi request reprint Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study
    Russell K Portenoy
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 10003, USA
    Clin J Pain 23:287-99. 2007
    ..To evaluate the outcomes associated with the use of controlled-release (CR) oxycodone for up to 3 years in the treatment of noncancer pain...
  4. ncbi request reprint Development and testing of a neuropathic pain screening questionnaire: ID Pain
    Russell Portenoy
    Beth Israel Medical Center, First Avenue at 16th Street, New York, NY 10003, USA
    Curr Med Res Opin 22:1555-65. 2006
    ..A second multicenter study evaluated reliability and validity. Patients (N = 308) treated by pain specialists completed ID Pain and validation measures...
  5. ncbi request reprint Appropriate use of opioids for persistent non-cancer pain
    Russell K Portenoy
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 10003, USA
    Lancet 364:739-40. 2004
  6. doi request reprint A multicenter, placebo-controlled, double-blind, multiple-crossover study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain
    Russell K Portenoy
    Beth Israel Medical Center, New York, NY 10003, USA
    Pain 151:617-24. 2010
    ..In this short-term study, FPNS was safe, well tolerated, and rapidly efficacious for BTCP...
  7. ncbi request reprint Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study
    Russell K Portenoy
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 0003, USA
    Curr Med Res Opin 23:223-33. 2007
    ..FBT was evaluated for BTP in opioid-treated patients with chronic low back pain--the first such study in a population with chronic non-cancer pain...
  8. ncbi request reprint A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer
    Russell K Portenoy
    Beth Israel Medical Center, New York, NY 10003, USA
    Clin J Pain 22:805-11. 2006
    ..This double-blind, randomized, placebo-controlled study evaluated the efficacy, safety, and tolerability of FBT in opioid-treated patients with cancer-related BTP...
  9. ncbi request reprint Opioid use and survival at the end of life: a survey of a hospice population
    Russell K Portenoy
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, New York 10003, USA
    J Pain Symptom Manage 32:532-40. 2006
    ..In a hospice population, survival is influenced by complex factors, many of which may not be measurable. Based on these findings, concern about hastening death does not justify withholding opioid therapy...
  10. ncbi request reprint Safety and tolerability of high doses of intrathecal fentanyl for the treatment of chronic pain
    Sulane Do Ouro
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY, USA
    J Opioid Manag 2:365-8. 2006
    ..Our experience highlights an expanding scope of practice in the use of IT opioids in general and fentanyl specifically and suggests that high-dose fentanyl can be used safely in highly selected patients...
  11. ncbi request reprint Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis
    Lauren Shaiova
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, First Avenue at 16th Street, New York, NY 10003, USA
    Support Care Cancer 12:268-73. 2004
    ..OTFC is effective for breakthrough pain and could be particularly useful in patients with mucositis...
  12. ncbi request reprint Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 2: impact on function, mood, and quality of life
    Russell K Portenoy
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, New York, USA
    J Opioid Manag 6:109-16. 2010
    ..Very few studies have evaluated BTP in populations with chronic noncancer pain. Data that illuminate the impact of BTP may not generalize to other, less selected patient populations...
  13. ncbi request reprint Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities
    Andrew Rosenblum
    Institute for Treatment and Services Research, National Development and Research Institutes, New York, NY 10010, USA
    JAMA 289:2370-8. 2003
    ..Little is known about the prevalence and characteristics of chronic pain among patients with different types of chemical dependency...
  14. pmc Pain in underserved community-dwelling Chinese American cancer patients: demographic and medical correlates
    Lara Dhingra
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, 120 East 16th Street, 12th Floor, New York, New York 10003, USA
    Oncologist 16:523-33. 2011
    ..The objective of this study was to describe the epidemiology of pain in this population. This information is needed to identify and address unmet clinical needs for culturally relevant interventions targeting pain and its consequences...
  15. ncbi request reprint Administration of morphine sulfate extended-release capsules via gastrostomy: dissolution study and case reports
    Lauren Shaiova
    Department of Pain Medicine and Palliative Care, Metropolitan Hospital Center, New York, New York 10019, USA
    J Palliat Med 10:1063-7. 2007
    ..The aim of this study was to target patients who had painful mucositis at grade III-IV and treat their radiation-induced mucositis with gastrostomy administered morphine in an extended-release dosing form...
  16. ncbi request reprint Adjuvant analgesics in cancer pain management
    David Lussier
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, First Avenue at 16th Street, New York, New York 10003, USA
    Oncologist 9:571-91. 2004
    ..This article reviews the evidence supporting the use of each class of adjuvant analgesic for the treatment of pain in cancer patients and provides a comprehensive outline of dosing recommendations, side effects, and drug interactions...
  17. ncbi request reprint Safety, tolerability and symptom outcomes associated with L-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I/II study
    Ricardo A Cruciani
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York 10003, USA
    J Pain Symptom Manage 32:551-9. 2006
    ..This study provides the basis for the design of future placebo-controlled studies of l-carnitine supplementation for cancer-related fatigue...
  18. ncbi request reprint U.S. board-certified pain physician practices: uniformity and census data of their locations
    Brenda Breuer
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 10003, USA
    J Pain 8:244-50. 2007
    ..Data are needed to further clarify the nature of workforce variation, its impact on patient care, and the role of other pain management clinicians...
  19. ncbi request reprint A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis
    Brenda Breuer
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, New York 1003, USA
    Clin Ther 29:2022-30. 2007
    ..Approximately 30% of patients with multiple sclerosis (MS) have central pain (CP). The anticonvulsant lamotrigine has been shown to be efficacious in some types of CP, but its efficacy in MS-related CP has not been confirmed...
  20. doi request reprint Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study
    Russell K Portenoy
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, New York 10003, USA
    J Pain Symptom Manage 35:458-68. 2008
    ..In conclusion, methylnaltrexone relieved opioid-induced constipation at doses >or=5mg in patients with advanced illness, and did not reduce analgesia or cause opioid withdrawal symptoms...
  21. ncbi request reprint Steady-state pharmacokinetic comparison of a new, extended-release, once-daily morphine formulation, Avinza, and a twice-daily controlled-release morphine formulation in patients with chronic moderate-to-severe pain
    Russell K Portenoy
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 10003, USA
    J Pain Symptom Manage 23:292-300. 2002
    ..The pharmacodynamic implications of this profile deserve further study...
  22. ncbi request reprint Monitoring outcomes during long-term opioid therapy for noncancer pain: results with the Pain Assessment and Documentation Tool
    Steven D Passik
    Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Opioid Manag 1:257-66. 2005
    ..e., addiction or diversion) in only approximately 10 percent of cases. Using the PADT physician ratings can be developed in four domains. In this sample, outcomes suggested that opioid therapy provided meaningful analgesia...
  23. doi request reprint Pain management by primary care physicians, pain physicians, chiropractors, and acupuncturists: a national survey
    Brenda Breuer
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 10003, USA
    South Med J 103:738-47. 2010
    ....
  24. ncbi request reprint Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 1: prevalence and characteristics
    Russell K Portenoy
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, New York, USA
    J Opioid Manag 6:97-108. 2010
    ..Studies in noncancer populations are limited to surveys of pain clinics and patients with other advanced diseases. To better understand BTP, data are needed from less selected populations...
  25. doi request reprint L-carnitine supplementation in patients with advanced cancer and carnitine deficiency: a double-blind, placebo-controlled study
    Ricardo A Cruciani
    Research Division, Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 10003, USA
    J Pain Symptom Manage 37:622-31. 2009
    ....
  26. doi request reprint Ecological momentary assessment of smoking behavior in persistent pain patients
    Lara K Dhingra
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York Departments of Neurology and Psychiatry and Behavioral Sciences Medicine Neurology and Anesthesiology, Albert Einstein College of Medicine Albert Einstein College of Medicine of Yeshiva University, Bronx Maimonides Medical Center, Brooklyn The New School for Social Research, New York, NY
    Clin J Pain 30:205-13. 2014
    ..Some studies suggest that pain activates smoking urges and others suggest that smoking is analgesic. We evaluated these associations using ecological momentary assessment, a method for real-time measurement of health-related phenomena...
  27. doi request reprint A qualitative study to explore psychological distress and illness burden associated with opioid-induced constipation in cancer patients with advanced disease
    Lara Dhingra
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 10003, USA
    Palliat Med 27:447-56. 2013
    ..Aim: The objective was to use qualitative research methods to better understand psychological distress and the burden associated with opioid-induced constipation and its treatment in advanced cancer patients...
  28. ncbi request reprint Developing an integrated Department of Pain and Palliative Medicine
    Russell Portenoy
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, New York 10003, USA
    J Palliat Med 5:623-33. 2002
  29. pmc Opioids and the treatment of chronic pain: controversies, current status, and future directions
    Andrew Rosenblum
    National Development and Research Institutes, New York, NY 10010, USA
    Exp Clin Psychopharmacol 16:405-16. 2008
    ....
  30. ncbi request reprint Long-term safety, tolerability, and consistency of effect of fentanyl pectin nasal spray for breakthrough cancer pain in opioid-tolerant patients
    Russell K Portenoy
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, New York, USA
    J Opioid Manag 6:319-28. 2010
    ..to assess the long-term safety, tolerability, and consistency of effect of fentanyl pectin nasal spray (FPNS) in patients with breakthrough cancer pain (BTCP)...
  31. doi request reprint MMTP patients with chronic pain switching to pain management clinics. A problem or an acceptable practice?
    Ricardo A Cruciani
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York 10003, USA
    Pain Med 9:359-64. 2008
    ..Research is needed to evaluate the phenomenology of pain and addiction in this population and the outcomes associated with varied therapeutic strategies...
  32. ncbi request reprint Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse
    Steven D Passik
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Clin J Pain 22:173-81. 2006
    ....
  33. ncbi request reprint Development and validation of the Brief Assessment Scale for Caregivers in Chinese
    Myra Glajchen
    1 Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, New York
    J Palliat Med 16:1394-402. 2013
    ..Chinese family caregivers in the United States experience high rates of burden. Studies in this population require culturally appropriate and valid instruments...
  34. ncbi request reprint Improving end-of-life care: development and pilot-test of a clinical pathway
    Marilyn Bookbinder
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, New York 10003, USA
    J Pain Symptom Manage 29:529-43. 2005
    ..Further study of this systems-oriented approach to change is warranted and should include direct assessment of patient and family outcomes, as well as measures of process...
  35. ncbi request reprint Opioid rotation in the management of refractory cancer pain
    Rose Anne Indelicato
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 10003, USA
    J Clin Oncol 21:87s-91s. 2003
  36. ncbi request reprint Population-based survey of pain in the United States: differences among white, African American, and Hispanic subjects
    Russell K Portenoy
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 10003, USA
    J Pain 5:317-28. 2004
    ..The data suggest that race and ethnicity contribute to clinical diversity, but socioeconomic disadvantage is the more important predictor of disabling pain...
  37. doi request reprint Prevalence and characteristics of chronic pain in patients admitted to an outpatient drug and alcohol treatment program
    Robert Sheu
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, New York 10003, USA
    Pain Med 9:911-7. 2008
    ..To evaluate the prevalence, characteristics, and correlates of chronic pain in a population of predominantly employed, alcoholic patients attending an outpatient drug and alcohol treatment program...
  38. ncbi request reprint Cancer pain management
    Russell K Portenoy
    Beth Israel Medical Center, New York, NY 10003, USA
    Clin Adv Hematol Oncol 3:30-2. 2005
  39. ncbi request reprint Access to care for chronic pain: racial and ethnic differences
    Marisa Nguyen
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York 10003, USA
    J Pain 6:301-14. 2005
    ..A national telephone survey suggests that race and ethnicity, along with other demographic and socioeconomic factors, influence access to care for chronic pain...
  40. ncbi request reprint Measurement of QTc in patients receiving chronic methadone therapy
    Ricardo A Cruciani
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, New York 10003, USA
    J Pain Symptom Manage 29:385-91. 2005
    ..Significant dose response was observed in males on methadone <12 months (rho=0.60, P=0.02). Our study suggests that methadone may prolong the QTc interval in specific subpopulations but poses little risk of serious prolongation...
  41. ncbi request reprint Opioid rotation in the management of refractory cancer pain
    Rose Anne Indelicato
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, First Ave at 16th Street, New York, NY 10003, USA
    J Clin Oncol 20:348-52. 2002
  42. doi request reprint Opioid rotation: the science and the limitations of the equianalgesic dose table
    Helena Knotkova
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY, USA
    J Pain Symptom Manage 38:426-39. 2009
    ..Review of these issues informs the use of opioid rotation in the clinical setting and defines key areas for future research...
  43. ncbi request reprint Management of fatigue in the cancer patient
    Pauline Lesage
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, New York 10003, USA
    Oncology (Williston Park) 16:373-8, 381; discussion 381-2, 385-6, 388-9. 2002
    ..Symptomatic interventions include specific drug treatment, modification of activity, exercise, and cognitive therapies...
  44. ncbi request reprint Development of a brief assessment scale for caregivers of the medically ill
    Myra Glajchen
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, New York 10003, USA
    J Pain Symptom Manage 29:245-54. 2005
    ..005; female caregivers, P=0.035). These results support the validity of the BASC as a brief instrument for caregiver burden...
  45. ncbi request reprint How to use antidepressants and anticonvulsants as adjuvant analgesics in the treatment of neuropathic cancer pain
    Amy A McDonald
    VA Western New York Healthcare System, USA
    J Support Oncol 4:43-52. 2006
  46. ncbi request reprint Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial
    Joseph S Gimbel
    Arizona Research Center, LLC, Phoenix, USA
    Neurology 60:927-34. 2003
    ..This controlled study evaluated the efficacy and safety of controlled-release (CR) oxycodone in subjects with moderate to severe pain due to diabetic neuropathy...
  47. ncbi request reprint Toward optimal health: the experts discuss chronic pain. Interview by Jodi Godfrey Meisler
    Russell K Portenoy
    J Womens Health Gend Based Med 11:341-5. 2002
  48. ncbi request reprint Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain
    Mark Palangio
    Abbott Laboratories, Morris Corporate Center, Parsippany, New Jersey 07054, USA
    J Pain Symptom Manage 23:355-68. 2002
    ..Controlled longitudinal studies are required to further evaluate the use of ER hydromorphone in patients with discrete chronic malignant or nonmalignant pain conditions...
  49. ncbi request reprint The measurement of symptoms in young children with cancer: the validation of the Memorial Symptom Assessment Scale in children aged 7-12
    John J Collins
    Pain and Palliative Care Service, The Children s Hospital at Westmead, Sydney, New South Wales 2145, Australia
    J Pain Symptom Manage 23:10-6. 2002
    ..Systematic symptom assessment may be useful in future epidemiological studies of symptoms and in cancer chemotherapy drug trials...
  50. ncbi request reprint A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy
    Steven D Passik
    Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, 800 Rose Street, CC449, Lexington, KY 40536 0093, USA
    Clin Ther 26:552-61. 2004
    ..During long-term treatment, this assessment should focus on a broad range of outcomes, each of which should be documented in the medical record...
  51. ncbi request reprint Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey
    Augusto Caraceni
    Neurology Unit Pain Therapy and Palliative Care Unit, National Cancer Institute of Milan, Via Venezian 1, Milan, Italy
    Palliat Med 18:177-83. 2004
    ..Further studies are needed to characterize subtypes of BKP. The uneven distribution of BKP reporting across pain specialists from different countries suggests that more standardized methods for diagnosing BKP are needed...
  52. ncbi request reprint Pain medicine and drug law enforcement: an important step toward balance
    David E Joranson
    J Pain Palliat Care Pharmacother 19:3-5. 2005
  53. ncbi request reprint Pharmacologic management of neuropathic pain: evidence-based recommendations
    Robert H Dworkin
    University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Pain 132:237-51. 2007
    ..Long-term studies, head-to-head comparisons between medications, studies involving combinations of medications, and RCTs examining treatment of central NP are lacking and should be a priority for future research...
  54. ncbi request reprint Myths about controlling pain
    June H Dahl
    University of Wisconsin Madison, USA
    J Pain Palliat Care Pharmacother 18:55-8. 2004
    ..Myths and misinformation about pain and its management often lead to poor therapy for patients in pain. Nine common myths about pain and its management are described and refuted...
  55. pmc Symptom distress and quality of life in patients with advanced congestive heart failure
    Craig D Blinderman
    Palliative Care Service, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    J Pain Symptom Manage 35:594-603. 2008
    ..A focus on ameliorating prevalent physical symptoms and psychological distress, along with supportive measures that promote functional mobility, may lead to an improvement in the overall quality of life in this patient population...
  56. ncbi request reprint Formal ABMS and ACGME recognition of hospice and palliative medicine expected in 2006
    Russell K Portenoy
    J Palliat Med 9:21-3. 2006
  57. doi request reprint Creating a shared vision
    Russell K Portenoy
    J Palliat Med 11:410-2. 2008
  58. ncbi request reprint Drug-induced prolongation of the QT interval
    Ricardo A Cruciani
    N Engl J Med 350:2618-21; author reply 2618-21. 2004
  59. ncbi request reprint Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery-- report of an expert panel
    Samuel J Hassenbusch
    Department of Neurosurgery, The University of Texas M D Anderson Cancer Center, Houston, 77030, USA
    J Pain Symptom Manage 27:540-63. 2004
    ..Based on the best available evidence and expert opinion, consensus recommendations were developed in all these areas. The panel's conclusions may provide a foundation for clinical practice and a rational basis for new research...
  60. doi request reprint Strengthening communities
    Russell K Portenoy
    J Palliat Med 11:671-2. 2008
  61. ncbi request reprint The road to formal recognition: the end is in sight
    Russell K Portenoy
    American Board of Hospice and Palliative Medicine
    J Palliat Med 8:266-8. 2005